 |
市場調査レポート
商品コード
1452864
早産診断用検査キットの世界市場：市場規模、シェア、成長分析 - 検査別、エンドユーザー別、産業予測（2024～2031年）Global Preterm Birth Diagnostic Test Kits Market Size, Share, Growth Analysis, By Test(Biochemical tests, ultrasound), By End-user(Hospitals, clinics) - Industry Forecast 2024-2031 |
||||||
| 早産診断用検査キットの世界市場：市場規模、シェア、成長分析 - 検査別、エンドユーザー別、産業予測（2024～2031年） |
|
出版日: 2024年03月09日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の早産診断用検査キットの市場規模は、2022年に4億4,678万米ドル、2023年に4億7,984万米ドルに達し、2024～2031年の予測期間中にCAGR 7.4％で成長し、2031年には8億4,944万米ドルに達すると予測されています。
早産診断用検査キットの世界市場は、早産の発生率の上昇と早期発見の必要性によって推進されています。これらのキットは、バイオマーカーや臨床指標の精査を通じて、早産の可能性を迅速かつ効果的に評価することを容易にします。同市場は、ヘルスケア専門家や妊産婦の意識の高まり、診断技術の進歩によって拡大しつつあります。北米と欧州は、その強固なヘルスケアインフラにより大きな市場シェアを占めています。一方、アジア太平洋は、ヘルスケア支出や意識の高まりにより、有望な成長を示しています。検査キット開発における継続的な研究と技術革新は、早産の世界の負担を軽減する目的で、市場の見通しをさらに強めています。市場の新たな動向として、ポイントオブケア検査が重視されるようになっており、患者の近くで早産リスクを迅速に評価できるようになっています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリ・プライマリデータソース
- 市場規模の推定
- 市場の前提条件・制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の早産診断用検査キット市場：検査別
- 市場概要
- 生化学検査
- 超音波
- 遺伝子スクリーニング
- 胎児フィブロネクチン検査
世界の早産診断用検査キット市場：エンドユーザー別
- 市場概要
- 病院
- クリニック
- 診断センター
- 研究機関
世界の早産診断用検査キット市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Roche Diagnostics（Switzerland）
- Abbott Laboratories（USA）
- Siemens Healthineers（Germany）
- Thermo Fisher Scientific（USA）
- BD（Becton, Dickinson and Company）（USA）
- PerkinElmer（USA）
- bioMerieux（France）
- Hologic, Inc.（USA）
- Qiagen（Netherlands）
- Danaher Corporation（USA）
- Cepheid（USA）
- Illumina, Inc.（USA）
- Sysmex Corporation（Japan）
- Agilent Technologies（USA）
- Bio-Rad Laboratories（USA）
- GenMark Diagnostics（USA）
- Luminex Corporation（USA）
- Randox Laboratories（United Kingdom）
- NanoString Technologies（USA）
- Myriad Genetics（USA）
Global Preterm Birth Diagnostic Test Kits Market size was valued at USD 446.78 million in 2022 and is poised to grow from USD 479.84 million in 2023 to USD 849.44 million by 2031, growing at a CAGR of 7.4% during the forecast period (2024-2031).
The Global Market for Preterm Birth Diagnostic Test Kits is being propelled by the escalating incidence of preterm births and the imperative for early identification. These kits facilitate prompt and effective evaluation of potential preterm births through the scrutiny of biomarkers and clinical indicators. The market is witnessing expansion driven by heightened awareness among healthcare professionals and expectant mothers, along with advancements in diagnostic technologies. North America and Europe command substantial market shares owing to their robust healthcare infrastructure. Conversely, Asia-Pacific exhibits promising growth due to increasing healthcare expenditure and awareness. Ongoing research and innovation in test kit development are further bolstering market prospects with the aim of alleviating the global burden of preterm births. An emerging trend in the market is the growing emphasis on point-of-care testing, allowing for swift assessments of preterm birth risk in proximity to the patient, which could prove crucial in regions with limited access to advanced healthcare facilities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preterm Birth Diagnostic Test Kits Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Preterm Birth Diagnostic Test Kits Market Segmental Analysis
The global market for preterm birth diagnostic test kits is segmented based on various factors such as test type, end-user, and region. Test types include biochemical tests, ultrasound, genetic screening, and fetal fibronectin tests. End-users comprise hospitals, clinics, diagnostic centers, and research institutions. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Drivers of the Global Preterm Birth Diagnostic Test Kits Market
Preterm birth, occurring prior to 37 weeks of pregnancy, stands as a prominent global health issue, prompting a growing need for precise and dependable diagnostic test kits to detect and forecast preterm labor. This demand is expected to endure, propelled by the escalating rates of preterm births, while healthcare providers and governments emphasize initiatives to decrease such occurrences and enhance maternal and neonatal health outcomes.
Restraints in the Global Preterm Birth Diagnostic Test Kits Market
The medical diagnostic sector operates under stringent regulations to guarantee patient safety and the effectiveness of products. The process of creating and introducing novel diagnostic test kits, particularly those associated with pregnancy and neonatal care, involves thorough testing and approval procedures. The presence of regulatory obstacles can prolong the release of new test kits, affecting their accessibility and widespread adoption in the market.
Market Trends of the Global Preterm Birth Diagnostic Test Kits Market
The market for diagnostic kits aimed at detecting preterm birth is expected to have progressed due to advancements in diagnostic technologies. These improvements likely encompass the creation of more precise and dependable tests, aiding healthcare professionals in predicting the risk of preterm birth with increased accuracy. The enhancements may involve incorporating a variety of biomarkers, genetic testing, proteomics, and other innovative strategies to elevate the sensitivity and specificity of diagnostic tests.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Preterm Birth Diagnostic Test Kits Market by Test
- Market Overview
- Biochemical tests
- ultrasound
- genetic screening
- and fetal fibronectin tests
Global Preterm Birth Diagnostic Test Kits Market by End-user
- Market Overview
- Hospitals
- clinics
- diagnostic centers
- and research institutions
Global Preterm Birth Diagnostic Test Kits Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BD (Becton, Dickinson and Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cepheid (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenMark Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NanoString Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Myriad Genetics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
